{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:58:59Z","timestamp":1793642339572,"version":"4.5.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003726.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000}}],"reference-count":122,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003726.pub4","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T08:14:35Z","timestamp":1497514475000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Tramadol for neuropathic pain in adults"],"prefix":"10.1002","volume":"2017","author":[{"given":"Rudolf Martin","family":"Duehmke","sequence":"first","affiliation":[{"name":"Papworth Hospital; Cardiac Unit; Papworth Everard Cambridge UK CB3 8RE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae F","family":"Bell","sequence":"additional","affiliation":[{"name":"Haukeland University Hospital; Regional Centre of Excellence in Palliative Care; Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Aldington","sequence":"additional","affiliation":[{"name":"Royal Hampshire County Hospital; Winchester UK SO22 5DG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD003726.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00044011-200727010-00007","article-title":"Tramadol in the treatment of neuropathic cancer pain. A double-blind, placebo-controlled study","volume":"27","author":"Arbaiza","year":"2007","journal-title":"Clinical Drug Investigation"},{"issue":"1-2","key":"10.1002\/14651858.CD003726.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0304-3959(03)00020-4","article-title":"Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial","volume":"104","author":"Boureau","year":"2003","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003726.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1212\/WNL.50.6.1842","article-title":"Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy","volume":"50","author":"Harati","year":"1998","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/AJP.0b013e31818a744d","article-title":"Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial","volume":"25","author":"Norrbrink","year":"2009","journal-title":"Clinical Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD003726.pub4-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0304-3959(99)00079-2","article-title":"Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003726.pub4-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1053\/cp.1999.v66.103171001","article-title":"The effect of tramadol in painful polyneuropathy in relation to serum drug and metabolite levels","volume":"66","author":"Sindrup","year":"1999","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD003726.pub4-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/j.1532-2149.2011.00069.x","article-title":"Randomized controlled trial of the combined monoaminergic and opioid investigational compound GRT9906 in painful polyneuropathy","volume":"16","author":"Sindrup","year":"2012","journal-title":"European Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD003726.pub4-BIB0008|cit8","first-page":"129","article-title":"Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy","volume":"14","author":"Ashry","year":"2001","journal-title":"Foot and Ankle Quarterly - The Seminar Journal"},{"issue":"1","key":"10.1002\/14651858.CD003726.pub4-BIB0009|cit9","first-page":"53","article-title":"Pharmacologic treatment of neuropathic pain","volume":"101","author":"Attal","year":"2001","journal-title":"Acta Neurologica Belgica"},{"issue":"2-3","key":"10.1002\/14651858.CD003726.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3959(97)00172-3","article-title":"Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain","volume":"74","author":"Benedetti","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0011|cit11","unstructured":"Erdine S Yucel A Ozyalcin S Efficacy of tramadol hydrochloride in chronic painful diabetic neuropathy: a double-blind placebo controlled study Proceedings of the 8th World Congress on Pain Seattle IASP Press 1997 371"},{"issue":"4","key":"10.1002\/14651858.CD003726.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2165\/00044011-199510040-00003","article-title":"Treatment of pain due to postherpetic neuralgia with tramadol","volume":"10","author":"Gobel","year":"1995","journal-title":"Clinical Drug Investigation"},{"issue":"6","key":"10.1002\/14651858.CD003726.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1212\/WNL.52.6.1300-a","article-title":"Tramadol for the treatment of the pain of diabetic neuropathy [Correspondence]","volume":"52","author":"Harati","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1056-8727(00)00060-X","article-title":"Maintenance of long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy","volume":"14","author":"Harati","year":"2000","journal-title":"Journal of Diabetes and its Complications"},{"issue":"Suppl","key":"10.1002\/14651858.CD003726.pub4-BIB0015|cit15","first-page":"32","article-title":"The use of oral opioids in neuropathic pain: development of new tramadol and morphine formulations","volume":"8","author":"Herrera Silva","year":"2001","journal-title":"Revista de la Sociedad Espanola del Dolor"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0016|cit16","first-page":"257","article-title":"Analgesic efficacy and side effects of oral tramadol and morphine administered orally in the treatment of cancer pain","volume":"51","author":"Leppert","year":"2001","journal-title":"Nowotwory"},{"issue":"6","key":"10.1002\/14651858.CD003726.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1212\/WNL.52.6.1300-a","article-title":"Tramadol for the treatment of the pain of diabetic neuropathy [Correspondence]","volume":"52","author":"Moulin","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0018|cit18","unstructured":"NCT00610155 A methodology study of brain imaging of pain-killers in post-traumatic neuropathic pain patients clinicaltrials.gov\/ct2\/show\/NCT00610155"},{"issue":"4","key":"10.1002\/14651858.CD003726.pub4-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.13040\/IJPSR.0975-8232.6(4).1489-01","article-title":"Neuropathic pain symptoms of post herpetic neuralgia patients with CYP2D6 polymorphism undergoing tramadol treatment","volume":"6","author":"Nasare","year":"2015","journal-title":"International Journal of Pharmaceutical Sciences and Research"},{"issue":"4","key":"10.1002\/14651858.CD003726.pub4-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1533-2500.2012.00583.x","article-title":"A randomized, prospective study of efficacy and safety of oral tramadol in the management of post-herpetic neuralgia in patients from north India","volume":"13","author":"Saxena","year":"2013","journal-title":"Pain Practice"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0021|cit21","first-page":"216","article-title":"Feasibility of transdermal fentanyl for pain relief of herpes zoster and postherpetic neuralgia","volume":"8","author":"Xiao","year":"2004","journal-title":"Zhongguo Linchuang Kangfu"},{"issue":"1-2","key":"10.1002\/14651858.CD003726.pub4-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pain.2008.07.013","article-title":"Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies","volume":"141","author":"Ho","year":"2009","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ijcard.2012.11.048","article-title":"Random error in cardiovascular meta-analyses: how common are false positive and false negative results?","volume":"168","author":"AlBalawi","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD003726.pub4-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1474-4422(11)70281-","article-title":"Chronic pain: genes, plasticity, and phenotypes","volume":"11","author":"Baron","year":"2012","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003726.pub4-BIB0025|cit25","first-page":"395","article-title":"Tramadol, pharmacology, side effects, and serotonin syndrome: a review","volume":"18","author":"Beakley","year":"2015","journal-title":"Pain Physician"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jpain.2003.12.004","article-title":"Clinical characteristics and economic costs of patients with painful neuropathic disorders","volume":"5","author":"Berger","year":"2004","journal-title":"Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD003726.pub4-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1533-2500.2008.00244.x","article-title":"Clinical and economic characteristics of patients with painful neuropathic disorders in Germany","volume":"9","author":"Berger","year":"2009","journal-title":"Pain Practice"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2377-12-8","article-title":"Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study","volume":"12","author":"Berger","year":"2012","journal-title":"BMC Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"issue":"12","key":"10.1002\/14651858.CD003726.pub4-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1460-9592.2005.01738.x","article-title":"Use of tramadol in children","volume":"15","author":"Bozkurt","year":"2005","journal-title":"Paediatric Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD003726.pub4-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0032|cit32","unstructured":"Bush DM Emergency department visits for drug misuse or abuse involving the pain medication tramadol The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013-. 2015"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0033|cit33","unstructured":"Tramadol for the management of pain in adult patients: a review of the clinical effectiveness Canadian Agency for Drugs and Technologies in Health"},{"issue":"7","key":"10.1002\/14651858.CD003726.pub4-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","article-title":"The role of the immune system in the generation of neuropathic pain","volume":"11","author":"Calvo","year":"2012","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005522.pub2","article-title":"Tramadol for osteoarthritis","author":"Cepeda","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003726.pub4-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008943.pub2","article-title":"Combination pharmacotherapy for the treatment of neuropathic pain in adults","author":"Chaparro","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"f2304","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD003726.pub4-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.2014.8166","article-title":"Association between analytic strategy and estimates of treatment outcomes in meta-analyses","volume":"312","author":"Dechartres","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD003726.pub4-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.pain.2014.08.014","article-title":"The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study","volume":"155","author":"Demant","year":"2014","journal-title":"Pain"},{"issue":"9","key":"10.1002\/14651858.CD003726.pub4-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010111","article-title":"Topical capsaicin (low concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0041|cit41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007393.pub3","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003726.pub4-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010958.pub2","article-title":"Topical lidocaine for neuropathic pain in adults","author":"Derry","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"11","key":"10.1002\/14651858.CD003726.pub4-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.pain.2013.06.004","article-title":"Interventional management of neuropathic pain: NeuPSIG recommendations","volume":"154","author":"Dworkin","year":"2013","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0885-3924(01)00404-3","article-title":"Combination analgesic efficacy: individual patient data meta-analysis of single-dose oral tramadol plus acetaminophen in acute postoperative pain","volume":"23","author":"Edwards","year":"2002","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0046|cit46","unstructured":"Effective Practice Organisation of Care (EPOC) 23. Worksheets for preparing a Summary of Findings using GRADE EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2015. Available at: http:\/\/epoc.cochrane.org\/epoc-specific-resources-review-authors"},{"issue":"7","key":"10.1002\/14651858.CD003726.pub4-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/j.1532-2149.2012.00282.x","article-title":"Neuropathic pain needs systematic classification","volume":"17","author":"Finnerup","year":"2013","journal-title":"European Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF03256239","article-title":"Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics","volume":"11","author":"Gan","year":"2007","journal-title":"Molecular Diagnosis and Therapy"},{"issue":"7","key":"10.1002\/14651858.CD003726.pub4-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010692.pub3","article-title":"Oxycodone for neuropathic pain in adults","author":"Gaskell","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"13","key":"10.1002\/14651858.CD003726.pub4-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clinical Pharmacokinetics"},{"issue":"1","key":"10.1002\/14651858.CD003726.pub4-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005","volume":"9","author":"Hall","year":"2008","journal-title":"BMC Family Practice"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cpt.19","article-title":"Individualized pharmacological treatment of neuropathic pain","volume":"97","author":"Helfert","year":"2015","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0058|cit58","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD003726.pub4-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0061|cit61","doi-asserted-by":"crossref","unstructured":"Jensen TS Baron R Haanp\u00e4\u00e4 M Kalso E Loeser JD Rice AS A new definition of neuropathic pain Pain 2011 2204 5 10.1016\/j.pain.2011.06.017","DOI":"10.1016\/j.pain.2011.06.017"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"f7339","DOI":"10.1136\/bmj.f7339","article-title":"Drugs for neuropathic pain","volume":"347","author":"Kalso","year":"2013","journal-title":"BMJ"},{"issue":"5-6","key":"10.1002\/14651858.CD003726.pub4-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000110284","article-title":"Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota 1945-1984","volume":"10","author":"Katusic","year":"1991","journal-title":"Neuroepidemiology"},{"issue":"1-3","key":"10.1002\/14651858.CD003726.pub4-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pain.2009.08.023","article-title":"Incidence of facial pain in the general population","volume":"147","author":"Koopman","year":"2009","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD003726.pub4-BIB0066|cit66","first-page":"889","article-title":"Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories","volume":"48","author":"Lintz","year":"1998","journal-title":"Arzneimittel-Forschung"},{"issue":"1","key":"10.1002\/14651858.CD003726.pub4-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0068|cit68","unstructured":"Martindale: the complete drug reference. Tramadol hydrochloride www.medicinescomplete.com\/mc\/ (accessed 9 January 2017) 2016"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0304-3959(95)00116-6","article-title":"Variation in the placebo effect in randomised controlled trials of analgesics: all is as blind as it seems","volume":"64","author":"McQuay","year":"1996","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0070|cit70","volume-title":"An Evidence-Based Resource for Pain Relief","author":"McQuay","year":"1998"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0071|cit71","article-title":"Chronic pain","volume-title":"Health Care Needs Assessment, 3rd Series","author":"McQuay","year":"2007"},{"issue":"7","key":"10.1002\/14651858.CD003726.pub4-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0304-3959(96)03291-5","article-title":"Single-patient data meta-analysis of 3453 postoperative patients: oral tramadol versus placebo, codeine and combination analgesics","volume":"69","author":"Moore","year":"1997","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0075|cit75","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD003726.pub4-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD003726.pub4-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD003726.pub4-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"1","key":"10.1002\/14651858.CD003726.pub4-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD003726.pub4-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub3","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD003726.pub4-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010902.pub2","article-title":"Oral nonsteroidal anti-inflammatory drugs for neuropathic pain","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003726.pub4-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub3","article-title":"Amitriptyline for neuropathic pain in adults","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD003726.pub4-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000088","article-title":"Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting","volume":"156","author":"Moore","year":"2015","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0092|cit92","unstructured":"National Institute for Health and Care Excellence (NICE) Neuropathic pain - pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist settings, 2013 www.nice.org.uk\/guidance\/cg173"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD003726.pub4-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0095|cit95","unstructured":"Cochrane Pain, Palliative and Supportive Care Group (PaPaS) author and referee guidance papas.cochrane.org\/papas-documents"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/08897077.2012.735216","article-title":"Topical review on the abuse and misuse potential of tramadol and tilidine in Germany","volume":"34","author":"Radbruch","year":"2013","journal-title":"Substance Abuse"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0304-3959(94)90086-8","article-title":"Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion","volume":"56","author":"Rappaport","year":"1994","journal-title":"Pain"},{"issue":"11","key":"10.1002\/14651858.CD003726.pub4-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1358\/dot.2008.44.11.1289441","article-title":"Tramadol: basic pharmacology and emerging concepts","volume":"44","author":"Reeves","year":"2008","journal-title":"Drugs of Today (Barcelona, Spain: 1998)"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0099|cit99","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"h2463","DOI":"10.1136\/bmj.h2463","article-title":"The knowledge system underpinning healthcare is not fit for purpose and must change","volume":"350","author":"Roberts","year":"2015","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0101|cit101","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0102|cit102","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD003726.pub4-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2165\/00003495-200060010-00008","article-title":"Tramadol: a review of its use in perioperative pain","volume":"60","author":"Scott","year":"2000","journal-title":"Drugs"},{"issue":"9","key":"10.1002\/14651858.CD003726.pub4-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","article-title":"The burden of herpes zoster: a prospective population based study","volume":"24","author":"Scott","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD003726.pub4-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011604.pub2","article-title":"Hydromorphone for neuropathic pain in adults","author":"Stannard","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.","article-title":"Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"5","key":"10.1002\/14651858.CD003726.pub4-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0269216311405090","article-title":"The second step of the analgesic ladder and oral tramadol in the treatment of mild to moderate cancer pain: a systematic review","volume":"25","author":"Tassinari","year":"2011","journal-title":"Palliative Medicine"},{"issue":"10","key":"10.1002\/14651858.CD003726.pub4-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1002\/14651858.CD003726.pub4-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"Journal of Pain"},{"issue":"18","key":"10.1002\/14651858.CD003726.pub4-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"e59202","DOI":"10.1371\/journal.pone.0059202","article-title":"The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1002\/14651858.CD003726.pub4-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"Hecke","year":"2014","journal-title":"Pain"},{"issue":"9","key":"10.1002\/14651858.CD003726.pub4-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.vaccine.2008.12.024","article-title":"Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales","volume":"27","author":"Hoek","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD003726.pub4-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype\u00a0to reveal neural mechanisms","volume":"73","author":"Hehn","year":"2012","journal-title":"Neuron"},{"issue":"9859","key":"10.1002\/14651858.CD003726.pub4-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003726.pub4-BIB0118|cit118","unstructured":"World Health Organization (WHO) WHO analgesic ladder www.who.int\/cancer\/palliative\/painladder\/en\/"},{"issue":"11","key":"10.1002\/14651858.CD003726.pub4-BIB0119|cit119","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0120|cit120","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003726","article-title":"Tramadol for neuropathic pain","author":"D\u00fchmke","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003726.pub4-BIB0121|cit121","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003726.pub2","article-title":"Tramadol for neuropathic pain","author":"D\u00fchmke","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003726.pub4-BIB0122|cit122","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003726.pub3","article-title":"Tramadol for neuropathic pain","author":"Hollingshead","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003726.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T05:01:20Z","timestamp":1696395680000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003726.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":122,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003726.pub4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727719790.793556095","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,15]]}}}